$75 Million Investment Fuels Ambitious Integration Plans

Oura Health just secured a $75 million investment from medical device giant Dexcom Inc., sending its valuation careering to over $5 billion.

Smart Rings and Glucose Monitoring to Revolutionize Health Tracking

This game-changing partnership will integrate Dexcom’s glucose monitoring technology with Oura’s health-tracking ecosystem, setting a new standard for personalized health insights.

The Deal That Changes Everything for Oura

Dexcom’s investment is part of Oura’s Series D funding round, marking a significant leap from its $2.6 billion valuation in 2022. The companies plan to blend their health technologies, making it easier for users to monitor glucose levels alongside fitness, sleep, and overall health metrics.

This partnership is about empowering people with data to make real lifestyle changes. [Hale, CEO, Oura]

Oura’s smart rings, priced from $249, are loved for tracking sleep patterns, fitness activity, and overall well-being without the bulk of a watch. Dexcom, meanwhile, is a leader in continuous glucose monitoring, providing health insights for people with diabetes and those aiming to optimize their metabolic health.

Why This Deal Matters

Dexcom recently launched its Stelo glucose monitor, a $99 arm-worn, prescription-free device that pairs seamlessly with mobile apps. With this collaboration, Oura’s platform will integrate Stelo’s glucose data, providing users with a holistic view of how glucose levels interact with sleep, nutrition, and activity.

For Dexcom, the deal is about reaching a broader audience says Dexcom’s Matt Dolan (corporate development)

When you combine glucose data with Oura’s insights, you’re giving users a powerful tool to understand their health

The Bigger Picture: Health Tech Arms Race

The race to dominate consumer health tech is heating up and the smart money moved here away from sports tech several years ago. Apple is believed to be developing noninvasive glucose-tracking technology that could transform its smartwatch into a health powerhouse. Samsung, another competitor in the smart ring space, is exploring glucose monitoring capabilities, too.

Hale revealed that Oura is already ahead of the curve on his customers’ trends noting,

One in five of our users has tried a continuous glucose monitor, and over half want to. Nearly all recognize the critical link between nutrition and overall health.

Next?

Integrating Dexcom’s glucose data into Oura’s app will happen early next year.

Oura’s finances are believed to be impressive

Oura is expected to double its revenue to $500 million this year alone. Despite rising competition and with over 2.5 million rings sold, the company dominates the smart ring market, though it’s holding off on going public—for now.